ArticleEMBO molecular medicine2022
The AhR-SRC axis as a therapeutic vulnerability in BRAFi-resistant melanoma.
Anaïs Paris et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it
ArticleEMBO molecular medicine2022
Anaïs Paris et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.